Freepoint Capital Group: Funding, Team & Investors | Startup Intros

Loading organizations...

Freepoint Capital Group: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 4, 2026	Third Arc Bio	Third Arc Bio Series A Extension	Andreessen Horowitz, Jorge Conde, Jorge Conde	AbbVie Ventures, abrdn, BVF Partners, Galapagos, Hillhouse Capital Group, Marshall Wace, Omega Funds, T. Rowe Price Associates
Jan 8, 2026	Parabilis Medicines	$305.0M Series F	Jake Simson	Catalio Capital Management, Foresite Capital, ARCH Venture Partners, Cormorant Asset Management, Farallon Capital Management, Frazier Life Sciences, General Catalyst, HBM Healthcare Investments, Invus, Marshall Wace, Milky Way Investments, Nextech Invest, Rock Springs Capital, Sixty Degree Capital, Soleus Capital, T. Rowe Price Associates
Aug 1, 2025	Strand Therapeutics	$150.0M Series B	Kinnevik	Decibel Partners, FPV Fund, Mozilla Ventures, Northzone, Playground Global, RRE Ventures, Sands Capital, Sapphire Ventures, Tiger Global Management, Work-Bench, Amgen Ventures, ANRI, Eli Lilly and Company, FPV Ventures, Gradiant Corporation, ICONIQ Growth, JIC Venture Growth Investments, LG Technology Ventures, Potentum Partners, Regeneron Ventures
Jul 1, 2024	Third Arc Bio	$170.0M Series A	Vida Ventures, Cormorant Asset Management, Hillhouse Capital Group	Sofinnova Investments, AbbVie Ventures, abrdn, BVF Partners, Foresite Capital, Goldman Sachs, Janus Henderson Investors, Logos Capital, Marshall Wace, Francesco Draetta, Loretta Tse, T. Rowe Price Associates